ProHTA^®

• Market Access
• Strategic Portfolio Planning and Technology Foresight
• Health Technology Assessment
• Health Economics and Outcomes Research (HEOR)
• Multi-Criteria Decision Analysis (MCDA)
• Modelling and Simulation

Previous ProHTA^® work has fo­cused on the evaluation of medical innovations (drugs and medical devices) in the area of

• Stroke
• Dementia
• Prostate Cancer
• Breast Cancer
• Chronic Heart Failure